Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Class I PDZ-domain proteins are a diverse group of scaffolding molecules defined by the presence of one or more PDZ domains that specifically recognize C-terminal peptide motifs with the consensus sequence Ser/Thr-X-Φ, where Φ represents a hydrophobic residue [1, 2]. These proteins are essential for the spatial organization of signaling pathways, as they facilitate the assembly of multi-protein complexes at specific subcellular locations, such as the postsynaptic density in neurons or tight junctions in epithelial cells [1, 3]. By anchoring receptors, ion channels, and enzymes to the cytoskeleton, Class I PDZ proteins regulate signal transduction efficiency and maintain cellular architecture and polarity [2, 5]. In pathological contexts, these proteins are often implicated in the progression of cancer through the loss of cell polarity or the over-activation of growth signaling, and in neurological conditions like ischemic stroke, where they mediate excitotoxic signaling complexes [4, 5]. Therapeutic targeting of Class I PDZ domains primarily focuses on the development of small molecules or peptidomimetics, such as Nerinetide, which disrupt specific protein-protein interactions to prevent disease-associated signaling without affecting the global function of the protein [4].
Inhibition of protein-protein interactions by competitive binding to the PDZ domain, disrupting the assembly of signaling complexes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Class I PDZ-domain proteins (Class I PDZ).